PRE-SATE Drug Patent Profile
Which patents cover Pre-sate, and when can generic versions of Pre-sate launch?
Pre-sate is a drug marketed by Parke Davis and is included in one NDA.
The generic ingredient in PRE-SATE is chlorphentermine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the chlorphentermine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PRE-SATE?
- What are the global sales for PRE-SATE?
- What is Average Wholesale Price for PRE-SATE?
Summary for PRE-SATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 27 |
| Patent Applications: | 70 |
| DailyMed Link: | PRE-SATE at DailyMed |
US Patents and Regulatory Information for PRE-SATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parke Davis | PRE-SATE | chlorphentermine hydrochloride | TABLET;ORAL | 014696-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
